Sarepta Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
11 Mar 24 | SellUS$93,550 | Kathryn Boor | Individual | 761 | US$122.93 | |
05 Mar 24 | SellUS$385,480 | Stephen Mayo | Individual | 3,135 | US$122.96 | |
01 Mar 24 | SellUS$153,960 | Ian Estepan | Individual | 1,200 | US$128.30 | |
01 Mar 24 | SellUS$257,676 | Bilal Arif | Individual | 2,000 | US$129.71 | |
01 Mar 24 | SellUS$250,680 | Ryan Brown | Individual | 2,000 | US$125.34 | |
03 Nov 23 | BuyUS$2,001,800 | Douglas Ingram | Individual | 25,225 | US$81.26 | |
03 Nov 23 | BuyUS$3,940,500 | Richard Barry | Individual | 50,000 | US$78.81 | |
14 Aug 23 | BuyUS$1,092,429 | Michael Chambers | Individual | 9,979 | US$109.89 | |
11 Aug 23 | BuyUS$2,559,272 | Michael Chambers | Individual | 23,686 | US$108.05 | |
10 Aug 23 | BuyUS$3,701,067 | Michael Chambers | Individual | 34,867 | US$106.26 |
Insider Trading Volume
Insider Buying: SRPT insiders have only sold shares in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 1,197 | 0.00127% |
State or Government | 62,307 | 0.0659% |
Individual Insiders | 4,143,912 | 4.38% |
General Public | 4,790,703 | 5.07% |
Institutions | 85,525,647 | 90.5% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
8,795,754 | US$1.1b | -0.23% | 0.02% | |||
5,960,370 | US$769.6m | -4.05% | 0.01% | |||
4,891,417 | US$631.6m | -8.5% | 0.27% | |||
4,817,517 | US$622.0m | 1.6% | 0.03% | |||
4,344,444 | US$561.0m | 0% | 6.97% | |||
3,245,798 | US$419.1m | -21.4% | 0.07% | |||
3,179,842 | US$410.6m | 0.05% | no data | |||
2,453,500 | US$316.8m | 103% | 2.25% | |||
2,436,515 | US$314.6m | -8.38% | 0.03% | |||
2,122,491 | US$274.1m | -11.5% | 0.01% | |||
2,052,217 | US$265.0m | -11.3% | 0.05% | |||
1,919,835 | US$247.9m | 131% | 7.32% | |||
1,575,592 | US$203.4m | 38.6% | 0.03% | |||
1,523,077 | US$196.7m | 13.4% | 0.21% | |||
1,520,370 | US$196.3m | 3.46% | 0.02% | |||
1,460,475 | US$188.6m | 0.42% | 0.09% | |||
1,348,447 | US$174.1m | -10.5% | 0.01% | |||
1,258,536 | US$162.5m | 15.3% | 0.11% | |||
1,078,346 | US$139.2m | 0% | 5.38% | |||
1,069,000 | US$138.0m | 6.21% | 10.24% | |||
1,044,416 | US$134.9m | 0% | 0.08% | |||
874,147 | US$112.9m | 35.7% | 0.1% | |||
836,849 | US$108.1m | 0% | 0.01% | |||
734,462 | US$94.8m | -41.9% | 0.01% | |||
697,500 | US$90.1m | 0% | 1.25% |